Home > > Europe And Global Chemiluminescence Immunoassay Market- Size, Share, Growth Rate, and Forecast
The Europe Chemiluminescence Immunoassay market was valued at $2,647.0 Million in 2023, and is projected to reach $4,032.4 Million by 2030 growing at a CAGR of 6.25% from 2024 to 2030. Consumables segment is expected to be the highest contributor to this market, with $1,781.1 Million in 2023, and is anticipated to reach $2,661.7 by 2030, registering a CAGR of 5.96%. Instruments segment is anticipated to reach $1,110.9 Million by 2030 with the highest CAGR of 7.53%. Consumables and Instruments segments collectively expected to account for about 92.6% share of the Europe Chemiluminescence Immunoassay market in 2023, with the former constituting around 67.3% share. Instruments and Consumables segments are expected to witness significant growth rates at a CAGR of 7.53% and 5.96% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 92.6% in the overall Europe Chemiluminescence Immunoassay market in 2023, and is anticipated to reach 93.6% by 2030. Product Instruments Consumables Software & Services Application Therapeutic Drug Monitoring Oncology Cardiology Endocrinology Infectious Disease Autoimmune Disease Other Applications End-use Hospitals Clinical Laboratories Pharmaceutical & Biotechnology Companies Other End-Uses BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Singapore Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA